Is This Healthcare Stock a Buy for Dividend Growth Investors?
A new research paper from a Federal Reserve economist estimates that the probability of the U.S. entering a recession in the next four quarters is slightly more than 50%. Due to numerous factors, it's more likely than not that the economy will soon experience a downturn.
With this information on hand, investors can prepare themselves and their portfolios for such an event by purchasing shares of companies operating in recession-resistant sectors of the economy. The medical devices giant Stryker (NYSE: SYK) is certainly a resilient company. But should investors seeking growing dividends buy the stock now? Let's dive into Stryker's fundamentals and valuation to find out.
Despite supply chain challenges that many companies have dealt with in recent quarters, Stryker reported strong first-quarter results for the period ended March 31. The company topped analysts' predictions for both net sales and non-GAAP (adjusted) diluted earnings per share (EPS) for the quarter.
Source Fool.com
